This biosensor demonstrates 96-98% recovery rates in biological samples, indicating effective COVID-19 screening via smartphone technology.
M. Moreover, the sensing performance of the developed biosensor in human saliva was evaluated, and the recovery rates were found to be 96-98%. For proof of concept, a smartphone-based near-field communication electrochemical analyzer was integrated into the developed biosensor for potentiometric measurements. This biosensor is promising, as the antifouling PNA probes provide a new concept for the development of sensitive biosensors for screening for COVID-19 in biological samples.
No takes yet. Share an insight, caveat, or question.
Özer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: